Resumen
Fecal microbiota transplant (FMT) is currently recommended for recurrent Clostridioides difficile infection. However, it is interesting to acknowledge the potential therapeutic role in other diseases associated with dysbiosis. This review will focus on the current and potential indications of FMT in gastrointestinal diseases, evaluating the available evidence and also exposing the necessary requirements to carry it out.
Título traducido de la contribución | Trasplante de microbiota fecal, su utilidad más allá de Clostridioides difficile en enfermedades gastrointestinales |
---|---|
Idioma original | Inglés |
Páginas (desde-hasta) | 223-230 |
Número de páginas | 8 |
Publicación | Gastroenterologia y Hepatologia |
Volumen | 45 |
N.º | 3 |
DOI | |
Estado | Publicada - 2021 |